PLASMAPP CO., LTD. Financials Plasmapp Co., Ltd.
Equities
A405000
KR7405000001
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,460 KRW | -2.19% |
|
-1.20% | -40.00% |
| 04-21 | Plasmapp Co., Ltd. announced that it expects to receive KRW 4.5 billion in funding | CI |
| 2023 | AdaptivEndo and Plasmapp Collaborate to Develop Sterilization Techniques for Flexible Endoscopy | CI |
Valuation
| Fiscal Period: December | 2022 | 2023 |
|---|---|---|
| Capitalization 1 | 100,986 | 79,583 |
| Enterprise Value (EV) 1 | 115,349 | 91,358 |
| P/E ratio | -5.21 x | -4.1 x |
| Yield | - | - |
| Capitalization / Revenue | 7.59 x | 6.16 x |
| EV / Revenue | 8.67 x | 7.07 x |
| EV / EBITDA | -7.07 x | -4.86 x |
| EV / FCF | -4,524,889 x | -5,976,455 x |
| FCF Yield | -0% | -0% |
| Price to Book | 10.8 x | 10.3 x |
| Nbr of stocks (in thousands) | 17,717 | 19,410 |
| Reference price 2 | 5,700 | 4,100 |
| Announcement Date | 23/03/23 | 20/03/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net sales 1 | 6,349 | 13,306 | 12,917 |
| EBITDA 1 | -9,816 | -16,317 | -18,796 |
| EBIT 1 | -10,644 | -17,408 | -20,572 |
| Operating Margin | -167.66% | -130.83% | -159.26% |
| Earnings before Tax (EBT) 1 | -21,682 | -17,681 | -18,792 |
| Net income 1 | -21,682 | -17,681 | -18,792 |
| Net margin | -341.53% | -132.88% | -145.48% |
| EPS 2 | -2,131 | -1,095 | -999.4 |
| Free Cash Flow | - | -25,492 | -15,286 |
| FCF margin | - | -191.59% | -118.34% |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 23/03/23 | 23/03/23 | 20/03/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net Debt 1 | - | 14,363 | 11,775 |
| Net Cash position 1 | 2,579 | - | - |
| Leverage (Debt/EBITDA) | - | -0.8802 x | -0.6265 x |
| Free Cash Flow | - | -25,492 | -15,286 |
| ROE (net income / shareholders' equity) | - | -179% | -215% |
| ROA (Net income/ Total Assets) | - | -35.3% | -33.8% |
| Assets 1 | - | 50,079 | 55,562 |
| Book Value Per Share 2 | 1,006 | 529.0 | 399.0 |
| Cash Flow per Share 2 | 596.0 | 281.0 | 364.0 |
| Capex 1 | 944 | 11,970 | 1,808 |
| Capex / Sales | 14.87% | 89.96% | 13.99% |
| Announcement Date | 23/03/23 | 23/03/23 | 20/03/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -40.00% | 35.97M | |
| +75.69% | 12.57B | |
| -25.35% | 7.28B | |
| +15.77% | 7.2B | |
| +14.52% | 5.47B | |
| -18.50% | 4.73B | |
| +14.91% | 4.09B | |
| -23.67% | 3.78B | |
| -30.22% | 2.63B | |
| +42.93% | 2.3B |
- Stock Market
- Equities
- A405000 Stock
- Financials Plasmapp Co., Ltd.